Leadoptik today announced the successful first-in-human clinical use of its FDA-cleared Last Inch Assessment (LIA) system.

When Leslie Keebler contracted the flu last winter, early-stage lung cancer was not on her radar. The 62-year-old from Munhall, a former smoker, underwent breathing treatments and a round of steroids ...

California's Leadoptik, developer of a miniaturized imaging platform for minimally invasive surgical procedures, has announced FDA 510(k) clearance for its Last Inch Assessment (LIA) technology, an ...

Please provide your email address to receive an email when new articles are posted on . Diagnostic yield was comparable between navigational bronchoscopy and CT-guided biopsy. Trial investigator ...

Investigators wanted to analyze the diagnostic performance of methylation-sensitive restriction enzyme digestion followed by sequencing using cell-free DNA and explore the cancer signal origin of the ...

Stage 1 lung carcinoid tumors are confined to the lung and have not spread to lymph nodes or distant organs. Tumors at this stage are typically small and localized, which often allows for curative ...